Technology Articles - Globe Of Blogs

Global Electric Motorbikes Market Growing at 5.0% CAGR Through 2034

According to Intel Market Research, the global Electric Motorbikes market is projected to grow from USD 10.96 billion in 2025 to USD 16.38 billion by 2034, registering a CAGR of 5.0%. Market expansion is driven by tightening emission regulations, rising fuel prices, advancements in battery technology, and increasing fleet adoption for delivery services across emerging economies.

Global Automotive LiDAR Market Growing at 50.4% CAGR Through 2032

According to Intel Market Research, the global Automotive LiDAR market is projected to grow from USD 868 million in 2024 to USD 11.9 billion by 2032, registering a CAGR of 50.4%. Market expansion is driven by accelerating adoption of autonomous vehicles, regulatory mandates for advanced safety features, and technological advancements in solid-state LiDAR reducing costs while improving performance.

Global ABF Substrate Market Growing at 10.6% CAGR Through 2032

According to Intel Market Research, the global ABF (Ajinomoto Build-up Film) Substrate market is projected to grow from USD 4,890 million in 2024 to USD 9,548 million by 2032, registering a CAGR of 10.6%. Market expansion is driven by increasing demand for advanced semiconductor packaging, rising adoption in high-performance computing, AI, and data center applications, and ongoing miniaturization in electronics.

Global Home Security Market Growing at 54.5% CAGR Through 2032

According to Intel Market Research, the global Home Security market is projected to grow from USD 4.44 billion in 2024 to USD 87.56 billion by 2032, registering a CAGR of 54.5%. Market expansion is driven by rising safety concerns, increasing adoption of smart home technologies, advancements in AI and IoT solutions, and the growing availability of DIY installation systems.

Global Recombinant Human Insulin Market Growing at 5.6% CAGR Through 2034

According to Intel Market Research, the global Recombinant Human Insulin market is projected to grow from USD 5.8 billion in 2025 to USD 9.7 billion by 2034, registering a CAGR of 5.6%. Market expansion is driven by rising global diabetes prevalence, technological advancements in biopharmaceutical manufacturing, increasing healthcare expenditure, and the shift from animal-derived insulin to recombinant human insulin due to superior efficacy and safety.